AMR > A silent pandemic According to current trends, antimicrobial resistance (AMR) could take 50 million lives each year by 2050. The Australian Medical Association(AMA) points to a number of challenges in the fight against AMR in Australia, including: 🔹 Poor public awareness of antimicrobial resistance 🔹 Weak antimicrobial stewardship practices 🔹 Poor incentives for antimicrobial R&D 🔹 Uncoordinated governance structures Lumos Diagnostics recognises this urgent call to action. As the AMA proposes solutions like establishing a Centre for Disease Control (CDC) and improving stewardship practices, we stand ready with diagnostic tools that support these objectives. Our FebriDx™ diagnostic tool helps clinicians in making precise decisions, ensuring antibiotics are used responsibly and effectively. It's time for coordinated global efforts to advance understanding, stewardship, and innovation against AMR. Read more about the AMA’s proposed solutions for AMR: https://bit.ly/LDX-AMA-AMR $LDX #LDX #Lumos #AMR #antibioticresistance #healthcare #Innovation #pointofcare #globalhealth
